Enterprise Intelligence – A lone wolf activity or a corporate capability? Andrew White of Novartis and Gabriel Anderbjörk of InTheo

7th September 1200 - 1300hrs (British Summer Time) / 1300-1400hrs (Central European Summer Time)

One can find them in any company, the “lone wolves of intelligence”, i.e. individual subject matter experts with a mandate “to keep themselves updated” but with no, or very limited, communication with the wider organization around them. They do a fantastic job in information gathering and specialist skills development and they even reduce the risk of market and technical errors, but is that really intelligence operations in its true meaning?

In this webinar hosted by CILIP K&IM special interest group, Andrew White of Novartis and Gabriel Anderbjörk of InTheo, the latter being the author of the original paper on this topic and Andrew being the presenter who took this topic as a case study to the Pharma CI conference in March this year, argues that it is not. With the Novartis intelligence operation as a case, Gabriel and Andrew will aim at providing some fundamental supporting arguments for that Market & Competitive Intelligence need to be deployed and managed as a strategic corporate capability, including but not limited to, embracing the good old principles of communities of practice.